¹Ú¼±Èñ(Park Sun-Hee) - °æÈñ´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
ÀåÀ翵(Jang Jae-Young) - °æÈñ´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
µ¿¼®È£(Dong Seok-Ho) - °æÈñ´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
±èÈ¿Á¾(Kim Hyo-Jong) - °æÈñ´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
±èº´È£(Kim Byung-Ho) - °æÈñ´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
À念¿î(Chang Young-Woon) - °æÈñ´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
Abstract
Helicobacter pylori is a well known major causative agent of chronic gastritis. In general, the inflammation induced by this organism is a chronic active gastritis, which develops into atrophic gastritis. It is well established that atrophic gastritis is one of the major risk factors of intestinal gastric cancer. Thus, severe long-lasting gastritis induced by H. pylori infection is considered for treatment to prevent gastric cancer. We experienced a case of dramatic eradication of H. pylori using a fifth-line salvage therapy in a patient with H. pylori-induced active gastritis during four years of follow-up.
Å°¿öµå
Gastritis, Helicobacter pylori, Salvage therapy, Treatment failure
KMID :
0931320140140010052
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)